(Updated - March 1, 2023 6:39 AM EST)

Guggenheim analyst Vamil Divan initiates coverage on Travere Therapeutics (NASDAQ: TVTX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE